nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.0584	0.0708	CcSEcCtD
Bimatoprost—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.055	0.0666	CcSEcCtD
Bimatoprost—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.0526	0.0637	CcSEcCtD
Bimatoprost—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.0353	0.0428	CcSEcCtD
Bimatoprost—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.0342	0.0414	CcSEcCtD
Bimatoprost—Cataract—Riluzole—amyotrophic lateral sclerosis	0.034	0.0412	CcSEcCtD
Bimatoprost—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.0304	0.0368	CcSEcCtD
Bimatoprost—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.0242	0.0293	CcSEcCtD
Bimatoprost—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.0235	0.0284	CcSEcCtD
Bimatoprost—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.0217	0.0263	CcSEcCtD
Bimatoprost—Asthma—Riluzole—amyotrophic lateral sclerosis	0.0203	0.0246	CcSEcCtD
Bimatoprost—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0195	0.0236	CcSEcCtD
Bimatoprost—Depression—Riluzole—amyotrophic lateral sclerosis	0.018	0.0218	CcSEcCtD
Bimatoprost—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.017	0.0206	CcSEcCtD
Bimatoprost—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.0163	0.0197	CcSEcCtD
Bimatoprost—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0161	0.0195	CcSEcCtD
Bimatoprost—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.016	0.0194	CcSEcCtD
Bimatoprost—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.016	0.0193	CcSEcCtD
Bimatoprost—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0184	CcSEcCtD
Bimatoprost—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0178	CcSEcCtD
Bimatoprost—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0146	0.0177	CcSEcCtD
Bimatoprost—Tension—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0168	CcSEcCtD
Bimatoprost—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0166	CcSEcCtD
Bimatoprost—AKR1C3—Retinoid metabolism and transport—PLB1—amyotrophic lateral sclerosis	0.0132	0.0788	CbGpPWpGaD
Bimatoprost—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0154	CcSEcCtD
Bimatoprost—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0151	CcSEcCtD
Bimatoprost—Cough—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0149	CcSEcCtD
Bimatoprost—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0148	CcSEcCtD
Bimatoprost—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.012	0.0146	CcSEcCtD
Bimatoprost—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.012	0.0145	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.012	0.0145	CcSEcCtD
Bimatoprost—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0143	CcSEcCtD
Bimatoprost—Infection—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0139	CcSEcCtD
Bimatoprost—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0137	CcSEcCtD
Bimatoprost—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0136	CcSEcCtD
Bimatoprost—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0126	CcSEcCtD
Bimatoprost—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0125	CcSEcCtD
Bimatoprost—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0124	CcSEcCtD
Bimatoprost—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0123	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00996	0.0121	CcSEcCtD
Bimatoprost—Pain—Riluzole—amyotrophic lateral sclerosis	0.00987	0.012	CcSEcCtD
Bimatoprost—PTGER3—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.009	0.0536	CbGpPWpGaD
Bimatoprost—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00828	0.01	CcSEcCtD
Bimatoprost—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00816	0.00989	CcSEcCtD
Bimatoprost—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00763	0.00924	CcSEcCtD
Bimatoprost—Rash—Riluzole—amyotrophic lateral sclerosis	0.00728	0.00881	CcSEcCtD
Bimatoprost—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00727	0.0088	CcSEcCtD
Bimatoprost—Headache—Riluzole—amyotrophic lateral sclerosis	0.00723	0.00876	CcSEcCtD
Bimatoprost—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00685	0.0083	CcSEcCtD
Bimatoprost—AKR1C3—Diseases associated with visual transduction—PLB1—amyotrophic lateral sclerosis	0.00676	0.0402	CbGpPWpGaD
Bimatoprost—PTGFR—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.00673	0.0401	CbGpPWpGaD
Bimatoprost—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—amyotrophic lateral sclerosis	0.0066	0.0393	CbGpPWpGaD
Bimatoprost—PTGER1—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.00659	0.0392	CbGpPWpGaD
Bimatoprost—Tafluprost—PTGS2—amyotrophic lateral sclerosis	0.00623	1	CrCbGaD
Bimatoprost—PTGER3—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.00508	0.0302	CbGpPWpGaD
Bimatoprost—AKR1C3—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00423	0.0252	CbGpPWpGaD
Bimatoprost—AKR1C3—Retinoid metabolism and transport—APOE—amyotrophic lateral sclerosis	0.00407	0.0243	CbGpPWpGaD
Bimatoprost—AKR1C3—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00382	0.0228	CbGpPWpGaD
Bimatoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.0038	0.0226	CbGpPWpGaD
Bimatoprost—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.00372	0.0221	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00351	0.0209	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00294	0.0175	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00279	0.0166	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00269	0.016	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.0025	0.0149	CbGpPWpGaD
Bimatoprost—AKR1C3—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.00238	0.0142	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00235	0.014	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00213	0.0127	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00209	0.0124	CbGpPWpGaD
Bimatoprost—AKR1C3—Diseases associated with visual transduction—APOE—amyotrophic lateral sclerosis	0.00208	0.0124	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00204	0.0122	CbGpPWpGaD
Bimatoprost—AKR1C3—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00169	0.01	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00161	0.0096	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00159	0.00947	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TPK1—amyotrophic lateral sclerosis	0.00157	0.00932	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00156	0.00927	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.00153	0.00913	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00131	0.00781	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00131	0.00781	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—VTA1—amyotrophic lateral sclerosis	0.00125	0.00745	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00122	0.00728	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00122	0.00726	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.0012	0.00715	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.0012	0.00714	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00111	0.00664	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00109	0.0065	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00105	0.00624	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000949	0.00565	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000948	0.00564	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000928	0.00553	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000912	0.00543	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000899	0.00535	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000892	0.00531	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00088	0.00524	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PLB1—amyotrophic lateral sclerosis	0.000858	0.00511	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000851	0.00506	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000816	0.00486	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.0008	0.00476	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000799	0.00476	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—VCP—amyotrophic lateral sclerosis	0.000765	0.00455	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000758	0.00451	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000734	0.00437	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000718	0.00428	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000694	0.00413	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000679	0.00404	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000663	0.00395	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000652	0.00388	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000645	0.00384	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000636	0.00379	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000623	0.00371	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000604	0.00359	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000601	0.00358	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000598	0.00356	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000585	0.00348	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000567	0.00338	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000565	0.00336	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000555	0.0033	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000549	0.00327	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CST3—amyotrophic lateral sclerosis	0.000549	0.00327	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000545	0.00324	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000539	0.00321	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000538	0.0032	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000535	0.00319	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000525	0.00312	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000519	0.00309	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000497	0.00296	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000488	0.0029	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000482	0.00287	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000477	0.00284	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000476	0.00284	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000472	0.00281	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00046	0.00274	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000455	0.00271	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000443	0.00264	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000415	0.00247	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000403	0.0024	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CASP9—amyotrophic lateral sclerosis	0.000399	0.00238	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000396	0.00236	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000395	0.00235	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000392	0.00234	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000384	0.00229	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000356	0.00212	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000349	0.00208	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ERBB4—amyotrophic lateral sclerosis	0.000342	0.00203	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.00034	0.00203	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000339	0.00202	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000331	0.00197	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000324	0.00193	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000318	0.0019	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000313	0.00186	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000311	0.00185	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000304	0.00181	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000296	0.00176	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000293	0.00175	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000293	0.00174	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00029	0.00172	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000281	0.00168	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000279	0.00166	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000269	0.0016	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APOE—amyotrophic lateral sclerosis	0.000264	0.00157	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000262	0.00156	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000253	0.00151	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000248	0.00148	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000239	0.00142	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000238	0.00142	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000233	0.00139	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000225	0.00134	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—APOE—amyotrophic lateral sclerosis	0.000221	0.00132	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000216	0.00129	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00021	0.00125	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000206	0.00123	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000199	0.00118	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000196	0.00117	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000192	0.00114	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000185	0.0011	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTGS2—amyotrophic lateral sclerosis	0.000181	0.00108	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000167	0.000992	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000162	0.000964	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000158	0.000943	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000157	0.000937	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000153	0.00091	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000152	0.000902	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000141	0.000842	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000125	0.000742	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000122	0.000726	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000118	0.000701	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000118	0.0007	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000115	0.000686	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000111	0.000662	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000107	0.000636	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000106	0.000629	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000104	0.000616	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.99e-05	0.000594	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.99e-05	0.000476	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.82e-05	0.000466	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.55e-05	0.000449	CbGpPWpGaD
